β-agonist safety and the elephant in the room?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Thorax

• Publication date

  2010-06-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.2010.137182PMID 20530119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A case–control study of vitamin D status and asthma in adults

  2010cited by this paper
• Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene

  2009cited by this paper
• Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol.

  2009cited by this paper
• Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy

  2009cited by this paper
• Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.

  2009influential reference
• Arginine-16 β2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol

  2006cited by this paper
• The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol.

  2003cited by this paper
• Blunted seasonal variation in serum 25-hydroxy vitamin D and increased risk of osteomalacia in vegetarian London Asians.

  1992cited by this paper

• Variation in airway remodelling genes and their role on asthma severity in children and young adults

  2011cites this paper